Despite holding nearly twice as many individual securities (197 vs 102), SCHG is actually more concentrated in its top three positions than QQQ, commanding 28.34% of total assets in Nvidia, Apple, and Microsoft compared to QQQ’s 22.09%. This paradox stems from SCHG’s fundamental weighting methodology, which overweights companies with the strongest forward earnings growth and revenue acceleration scores—a formula that has consistently placed the same mega-cap tech triumvirate at the top. For investors, this means SCHG does not offer the “broad diversification” that its 197 holdings count implies; instead, it provides a quality-tilted mega-cap growth play where the bottom 194 holdings collectively represent less than 72% of the fund. QQQ, despite having fewer names, spreads its top three weight across a slightly smaller percentage, giving it marginally better top-tier diversification. The practical implication is that neither ETF is truly diversified—both are mega-cap tech bets, and your choice should rest on whether you want that exposure filtered through a quality screen (SCHG) or a pure market-cap Nasdaq rank (QQQ).

QQQ is constrained by a geographic rule that prohibits it from owning any company listed on the New York Stock Exchange (NYSE), which means it permanently excludes massive growth engines such as Visa, Mastercard, UnitedHealth, and JPMorgan Chase—all of which are eligible for SCHG. This exchange limitation is not a methodological choice; it is a mechanical consequence of tracking the Nasdaq-100 index, which only includes non-financial firms trading on the Nasdaq. SCHG, by contrast, scans the entire investable U.S. equity universe across the NYSE, Nasdaq, and even the Cboe BZX Exchange, allowing it to capture growth wherever it emerges. In practice, this means that during periods when NYSE-listed growth sectors (like healthcare IT or payments processing) outperform, SCHG has a structural advantage that QQQ can never replicate. For long-term investors, this is a critical blind spot: QQQ’s historical outperformance is partially a function of Nasdaq-listed tech’s dominance over the past decade, but there is no guarantee that the next ten years will follow the same exchange-specific distribution.

SCHG does not simply track the largest growth stocks; it employs a proprietary six-factor scoring model that blends three forward-looking variables (forward P/E, projected earnings growth, and price-to-book ratios) with three trailing fundamental variables (revenue growth, dividend yield, and net earnings growth). This actively adjusted quality index is rebalanced quarterly, meaning it can downgrade a high-flying momentum stock if its forward P/E becomes excessive or its earnings growth decelerates—even if the stock’s market cap continues to rise. QQQ, in contrast, uses a pure market-cap weighting system that mechanically increases exposure to companies as their share prices rise, creating a momentum-chasing feedback loop that can amplify both gains and losses. The result is that SCHG’s beta of 1.12—lower than QQQ’s 1.18—reflects this quality tilt, providing a more stable growth profile during market corrections. For cost-conscious investors, this quality screen reduces the need for active management while maintaining institutional-grade fundamental oversight at a passive ETF price point.

Most online comparisons miss a critical operational nuance: Invesco’s securities lending program generates revenue that partially offsets QQQ’s expense ratio, effectively lowering the net cost below the stated 0.18% for institutional holders. However, the more important oversight is that long-term retail investors should not be comparing SCHG to QQQ at all—they should compare it to QQQM, Invesco’s smaller, lower-cost sister fund that charges 0.15% and is designed specifically for buy-and-hold investors. QQQM trades at a fraction of QQQ’s daily volume (approximately 5-10% of QQQ’s $50+ billion average daily turnover), making it less suitable for active traders but identical in holdings and performance for long-term holders. Yet QQQM’s AUM of roughly $4.8 billion (as of June 2026) is a fraction of QQQ’s $492.3 billion, revealing that the vast majority of retail investors are unknowingly overpaying for liquidity they do not need. When you stack SCHG’s 0.04% fee against QQQM’s 0.15%, the delta shrinks to 0.11%—but SCHG still maintains a meaningful cost advantage while offering broader exchange exposure and fundamental screening.

SCHG wins the long-term core portfolio battle due to its 0.14% fee advantage, broader fundamental screening, and lower volatility—making it the ideal choice for retirement savers who prioritize compounding efficiency over chasing short-term momentum. QQQ wins the performance and liquidity war, however, for active traders, options writers, and tech-heavy growth bulls who demand the purest Nasdaq exposure and the highest historical returns. Buy SCHG if you are building a 20-year retirement portfolio and want quality-driven growth with minimal cost drag. Buy QQQ if you are an active trader or a concentrated tech bull who believes the Nasdaq’s largest names will continue to outpace the broader market, and you are comfortable with the higher fee and volatility.

You want SCHG based on the comparison data above. Check the fee, performance, and composition metrics for your specific goals.

You want QQQ based on the comparison data above. Consider your investment timeline and risk tolerance.

Both ETFs carry market risk. Past performance does not guarantee future results. Consider your full portfolio before choosing.